“From Generic to Biosimilar Drugs: Why Take an Innovative Pace?”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 13, no. 3S, Dec. 2012, pp. 21-27, https://doi.org/10.7175/fe.v13i3S.328.